Celldex Therapeutics, Inc. (CLDX) — SC 13G Filings
All SC 13G filings from Celldex Therapeutics, Inc.. Browse 3 Passive Stake Filing reports with AI-powered summaries and risk analysis.
SC 13G Filings (3)
- SC 13G Filing — Feb 14, 2024
- SC 13G Filing — Feb 14, 2024
-
Polar Capital Holdings Plc Reports 5.0% Stake in Celldex Therapeutics
— Feb 13, 2024 Risk: low
Polar Capital Holdings Plc, a UK-based investment firm, reported on February 13, 2024, that it beneficially owned 3,369,825 shares of Celldex Therapeutics, Inc.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX